ARTICLE | Company News
Cubist, TerraGen Discovery deal
October 30, 2000 8:00 AM UTC
CBST completed its acquisition of TerraGen for 608,000 CBST shares valued at $29 million (see BioCentury, Aug. 14). TerraGen provides directed biosynthesis technology and expertise in small molecule discovery from microbes. ...